Ethics, biotechnology, and global health: The development of vaccines in transgenic plants

Jason Robert, Dwayne Kirk

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

As compared with conventional vaccine production systems, plant-made vaccines (PMVs) are said to enjoy a range of advantages including cost of production and ease of storage for distribution in developing countries. In this article, we introduce the science of PMV production, and address ethical issues associated with development and clinical testing of PMVs within three interrelated domains: PMVs as transgenic plants; PMVs as clinical research materials; and PMVs as agents of global health. We present three conclusions: first, while many of the ethical issues raised by PMVs are familiar, PMVs add a new dimension to old issues, and raise some novel issues for ethicists and policy-makers; secondly, it is premature to promise broad applicability of PMVs across the developing world without having demonstrated their feasibility; thirdly, in particular, proponents of PMVs as a solution to global health problems must, as a condition of the ethical conduct of their research, define the commercial feasibility of PMVs for distribution in the developing world.

Original languageEnglish (US)
JournalAmerican Journal of Bioethics
Volume6
Issue number4
DOIs
StatePublished - Aug 1 2006

Fingerprint

transgenic plant
Genetically Modified Plants
vaccine
biotechnology
Biotechnology
ethics
Ethics
Vaccines
developing world
health
Global Health
Ethicists
Administrative Personnel
Research
production system
Developing Countries

Keywords

  • Bioethics
  • Clinical testing
  • Developing countries
  • Genetic engineering
  • Plant vaccines

ASJC Scopus subject areas

  • Management, Monitoring, Policy and Law

Cite this

Ethics, biotechnology, and global health : The development of vaccines in transgenic plants. / Robert, Jason; Kirk, Dwayne.

In: American Journal of Bioethics, Vol. 6, No. 4, 01.08.2006.

Research output: Contribution to journalArticle

@article{3f67f199479f4456aaff8966bbdc0b6d,
title = "Ethics, biotechnology, and global health: The development of vaccines in transgenic plants",
abstract = "As compared with conventional vaccine production systems, plant-made vaccines (PMVs) are said to enjoy a range of advantages including cost of production and ease of storage for distribution in developing countries. In this article, we introduce the science of PMV production, and address ethical issues associated with development and clinical testing of PMVs within three interrelated domains: PMVs as transgenic plants; PMVs as clinical research materials; and PMVs as agents of global health. We present three conclusions: first, while many of the ethical issues raised by PMVs are familiar, PMVs add a new dimension to old issues, and raise some novel issues for ethicists and policy-makers; secondly, it is premature to promise broad applicability of PMVs across the developing world without having demonstrated their feasibility; thirdly, in particular, proponents of PMVs as a solution to global health problems must, as a condition of the ethical conduct of their research, define the commercial feasibility of PMVs for distribution in the developing world.",
keywords = "Bioethics, Clinical testing, Developing countries, Genetic engineering, Plant vaccines",
author = "Jason Robert and Dwayne Kirk",
year = "2006",
month = "8",
day = "1",
doi = "10.1080/15265160600843551",
language = "English (US)",
volume = "6",
journal = "American Journal of Bioethics",
issn = "1526-5161",
publisher = "Routledge",
number = "4",

}

TY - JOUR

T1 - Ethics, biotechnology, and global health

T2 - The development of vaccines in transgenic plants

AU - Robert, Jason

AU - Kirk, Dwayne

PY - 2006/8/1

Y1 - 2006/8/1

N2 - As compared with conventional vaccine production systems, plant-made vaccines (PMVs) are said to enjoy a range of advantages including cost of production and ease of storage for distribution in developing countries. In this article, we introduce the science of PMV production, and address ethical issues associated with development and clinical testing of PMVs within three interrelated domains: PMVs as transgenic plants; PMVs as clinical research materials; and PMVs as agents of global health. We present three conclusions: first, while many of the ethical issues raised by PMVs are familiar, PMVs add a new dimension to old issues, and raise some novel issues for ethicists and policy-makers; secondly, it is premature to promise broad applicability of PMVs across the developing world without having demonstrated their feasibility; thirdly, in particular, proponents of PMVs as a solution to global health problems must, as a condition of the ethical conduct of their research, define the commercial feasibility of PMVs for distribution in the developing world.

AB - As compared with conventional vaccine production systems, plant-made vaccines (PMVs) are said to enjoy a range of advantages including cost of production and ease of storage for distribution in developing countries. In this article, we introduce the science of PMV production, and address ethical issues associated with development and clinical testing of PMVs within three interrelated domains: PMVs as transgenic plants; PMVs as clinical research materials; and PMVs as agents of global health. We present three conclusions: first, while many of the ethical issues raised by PMVs are familiar, PMVs add a new dimension to old issues, and raise some novel issues for ethicists and policy-makers; secondly, it is premature to promise broad applicability of PMVs across the developing world without having demonstrated their feasibility; thirdly, in particular, proponents of PMVs as a solution to global health problems must, as a condition of the ethical conduct of their research, define the commercial feasibility of PMVs for distribution in the developing world.

KW - Bioethics

KW - Clinical testing

KW - Developing countries

KW - Genetic engineering

KW - Plant vaccines

UR - http://www.scopus.com/inward/record.url?scp=33746812555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746812555&partnerID=8YFLogxK

U2 - 10.1080/15265160600843551

DO - 10.1080/15265160600843551

M3 - Article

C2 - 16885087

AN - SCOPUS:33746812555

VL - 6

JO - American Journal of Bioethics

JF - American Journal of Bioethics

SN - 1526-5161

IS - 4

ER -